CHEPLAPHARM ARZNEIMITTEL GMBH
502074-9890ActiveGlobal platform acquiring and developing established specialty pharmaceutical brands.
Oversigt
- 0
- Medarbejdere
- 100–500mio SEK
- Omsætning
- 2014
- Grundlagt
Nøglebeslutningstagere
Fabian Franke
Head of Investor Relations
Fabian Kunick
Senior Director Treasury & Investor Relations
Pierre Lüders
Head of Compliance, Export Control & Data Protection
Artem Gevorkyan
Senior Vice President Corporate Business Development
+14 flere kontakter i Funnelfeedr
Beskrivelse
CHEPLAPHARM Arzneimittel GmbH is a globally active company headquartered in Germany, dedicated to building a sustainable platform for Specialty Pharma. Their core business involves investing in and carefully developing long-established, trusted branded pharmaceutical products acquired from research-...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Ukendt
- Juridisk form
- Utländsk juridisk person
- Momsnummer
- SE502074989001
Beslutningstagere
18 kontakter i FunnelfeedrFabian Franke
Head of Investor Relations
Fabian Kunick
Senior Director Treasury & Investor Relations
Pierre Lüders
Head of Compliance, Export Control & Data Protection
Artem Gevorkyan
Senior Vice President Corporate Business Development
Sebastian Braun
Chief Executive Officer
Sandra Schröder
Vice President Scientific
Caroline Jacquin
Managing Director France
Keyarasch Parssanedjad
Chief Financial Officer
Klaus Köhl
Chief Operating Officer
Tamás Szóga
Vice President Commercial
Edeltraud M. Lafer
Co-Chief Executive Officer
Dr. Markus Peterseim
Chief Technology Officer
Urška Škof Bušs
Vice President Global Integrations & Separations
Dr. Kia Parssanedjad
Chief Financial Officer
Karl "Charly" Lang
Vice President Supply Chain Logistics
Bianca Y. Juha
Chief Scientific Officer
Stephanie Lemke
Senior Investor Relations Manager
Andre kontakter
Anna Rautenberg
Senior Specialist Compliance
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrINFECTOPHARM ARZNEIMITTEL UND CONSILIUM GMBH
0 medarbejdereFamily-owned German pharmaceutical company specializing in innovative medicines.
Immedica Pharma AB
50–99 medarbejdereCommercializing rare disease medicines globally through strategic partnerships.
Santhera Pharmaceuticals (Sweden) AB
1–4 medarbejdereSwiss specialty pharma developing treatments for rare neuromuscular diseases.
Immedica Bidco AB
1–4 medarbejdereCommercializing rare disease medicines globally through strategic partnerships.
INFECTOPHARM ARZEIMITTEL UND CONSILIUM GMBH
Family-owned firm developing innovative, patient-centered established medications.
Udforsk mere
Spørgsmål om CHEPLAPHARM ARZNEIMITTEL GMBH
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo